But weight loss with GLP-1s isnt instant, and it isnt identical for everyone
At the beginning of 2017, I became the Medical Director at Calista, where I perform and supervise clinical procedures
found that irisin-mediated p53 reduction decreases ferroptosis and protects cardiomyocytes against high-glucose injury by increasing SIRT1, decreasing p53 K382 acetylation to promote p53 degradation, and consequently upregulating SLC7A11 and GPX4 [108]
"Glutathione Deficiency during Early Postnatal Development Causes Schizophrenia-Like Symptoms and a Reduction in BDNF Levels in the Cortex and Hippocampus of Adult SpragueDawley Rats"

While mild, occasional sweating during tirzepatide treatment may not require immediate medical attention, certain patterns and accompanying symptoms warrant prompt evaluation by a healthcare provider: Call 911 or go to the emergency department if sweating occurs with: Signs of severe hypoglycemia: confusion, severe shakiness, difficulty speaking, loss of consciousness, or seizures (requiring assistance from others) Chest pain, shortness of breath, or irregular heartbeat Severe abdominal pain, particularly if radiating to the back (potential pancreatitis) Signs of severe dehydration: decreased urination, extreme thirst, dizziness, or fainting Allergic reaction symptoms: rash, hives, facial swelling, or difficulty breathing Contact your doctor within 2448 hours if you experience: Persistent or worsening night sweats that disrupt sleep Sweating accompanied by fever, fatigue, or weight loss that is unexpected or outside your treatment plan Sweating episodes that consistently occur after meals or at specific times New-onset sweating that began after starting tirzepatide or increasing the dose Sweating severe enough to require frequent clothing changes or that interferes with daily activities Your healthcare provider will likely assess blood glucose patterns, review concurrent medications, evaluate hydration status, and consider whether dose adjustment is appropriate
